The new treatment involves stimulating cells in the retina with light in a process called ‘photobiomodulation.’ More: First patient recruited in global AMD trial Source: News
read moreThe procedure involves inserting a device directly into the brain to stimulate hearing pathways. More: NHS set to fund brain surgery for deaf children Source: News
read moreTaltz is also approved to treat adults with moderate-to-severe plaque psoriasis. More: Positive results for Eli Lilly’s Taltz in late stage non-radiographic axial spondyloarthritis trial Source: News
read moreThe device generates a low-level electrical pulse and connects via a wire to a small patch that adheres to a patient’s forehead. More: FDA permits marketing of first non-drug treatment for ADHD Source: News
read moreA second draft of Chinese legislation designed specifically to crack down on vaccine malpractices has been put in front of the country’s top lawmakers—and it entails some tougher penalties that could reach 30 times the product value involved. More: China's
read moreOn the cusp of Zolgensma’s landmark FDA approval, Novartis has big hopes for the first-ever gene therapy for spinal muscular atrophy. But a patient’s death in the treatment’s European trial could throw a wrench into its plans. More: Novartis unveils investigation of infant's death in
read more© 1994 - 2026 B.M. Pharmaceuticals